Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The results of the trial align with earlier studies conducted in Europe, where UroShield improved patient outcomes.

Thanks to the expected introduction of several late-stage pipeline products. The type 1 diabetes (T1D) market across the ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

The heart failure market is expected to grow at a 9.6% CAGR from $13.5bn in 2022 to $33.7bn in 2032 in the 7MM.

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it ...